WallStSmart
CMMB

Chemomab Therapeutics Ltd DRC

NASDAQ: CMMB · HEALTHCARE · BIOTECHNOLOGY

$1.77
-1.67% today

Updated 2026-06-05

Market cap
$12.96M
P/E ratio
P/S ratio
EPS (TTM)
$-1.12
Dividend yield
52W range
$1 – $5
Volume
0.0M

Chemomab Therapeutics Ltd DRC (CMMB) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Total assets$9.48M$3.52M$5.65M$2.09M$12.76M$19.76M$12.48M$64.35M$43.06M$22.15M$16.96M$13.81M
Cash & equivalents$5.72M$2.21M$4.56M$1.45M$7.52M$17.58M$11.67M$14.69M$13.52M$9.29M$6.07M$7.56M
Current assets$9.16M$3.10M$4.87M$1.59M$10.92M$18.21M$11.84M$62.69M$41.74M$20.90M$16.04M$13.42M
Total liabilities$6.19M$1.37M$2.36M$2.70M$2.96M$4.85M$1.67M$2.89M$6.84M$5.15M$3.43M$1.48M
Current liabilities$4.89M$1.33M$2.36M$2.70M$2.75M$4.12M$1.32M$2.65M$6.75M$4.84M$3.22M$1.48M
Long-term debt
Shareholder equity$3.29M$2.14M$3.29M$-609000.00$9.80M$12.37M$10.80M$61.47M$36.22M$17.00M$13.54M$12.33M
Retained earnings$-112.75M$-47.46M$-52.70M$-62.88M$-78.31M$-17.74M$-23.70M$-36.17M$-63.82M$-88.68M$-102.62M$-111.62M
Accounts receivable$192170.00$129785.00$139009.00$88000.00$3.40M$636000.00$74000.00$179000.00$459000.00$289000.00$263000.00$3.06M
Inventory$1.00$-77000.00$-542.00$-657000.00$-1.35M$-1.04M$1.00
Goodwill

Frequently asked questions

How much free cash flow does CMMB generate?

CMMB produced $-11.22M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is CMMB's balance sheet healthy?

CMMB holds $7.56M in cash and equivalents against — in long-term debt, on $12.33M of shareholder equity. That debt is best read against the cash flow the business throws off each year.